- Supported exchanges /
- STU /
- 9SO.STU
Solasia Pharma K.K (9SO STU) stock market data APIs
Solasia Pharma K.K., a specialty pharmaceutical company, develops, imports/exports, and markets pharmaceutical products and medical devices, etc. in Japan. It offers SP-01 Sancuso, a transdermal delivery system that delivers the anti-emetic and granisetron into the patient"s bloodstream to patients receiving chemotherapy; and SP-02 Darinaparsin, a mitochondrial-targeted agent for the treatment of various hematologic and solid cancers, as well as SP-03 episil, an oral liquid for the treatment of pain associated with oral mucositis. The company was founded in 2006 and is based in Tokyo, Japan.
Solasia Pharma K.K Financial Data Overview
| 0.308 | |
| 0.308 | |
| - | |
| 0.308 | |
| 0.308 | |
| 0.136-0.418 | |
| 19 899 K | |
| 64 608 K | |
| 4 516 K | |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Solasia Pharma K.K Fundamental Data is available in our Financial Data APIs
- Net Revenue 4 516 K
- EBITDA 0
- Earnings Per Share -0.166
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Solasia Pharma K.K Earnings via APIs
- Latest Release 2024-11-11
- EPS/Forecast NaN
Get Solasia Pharma K.K End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
